ClinVar Miner

Submissions for variant NM_007294.3(BRCA1):c.4410A>T (p.Glu1470Asp) (rs80357075)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000120257 SCV000108679 likely benign not specified 2018-03-02 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV000131557 SCV000186560 benign Hereditary cancer-predisposing syndrome 2015-03-19 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000724288 SCV000225889 uncertain significance not provided 2016-01-11 criteria provided, single submitter clinical testing
Invitae RCV000724288 SCV000254987 likely benign not provided 2019-03-03 criteria provided, single submitter clinical testing
Color RCV000131557 SCV000688501 likely benign Hereditary cancer-predisposing syndrome 2016-07-11 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000120257 SCV000699148 likely benign not specified 2018-03-08 criteria provided, single submitter clinical testing Variant summary: BRCA1 c.4410A>T (p.Glu1470Asp) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 246024 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in BRCA1 causing Hereditary Breast and Ovarian Cancer (2e-05 vs 1e-03), allowing no conclusion about variant significance. The variant, c.4410A>T, has been reported in the literature in individuals affected with Hereditary Breast and Ovarian Cancer (Borg_2010, Dutil_2012, Judkins_2005). These report(s) do not provide unequivocal conclusions about association of the variant with Hereditary Breast and Ovarian Cancer. Co-occurrences with other pathogenic variant(s) have been reported (BRCA2 c.3922G>T, p.Glu1308X - 3 separate individuals), providing supporting evidence for a benign role. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant (Woods_2016). Multiple ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cite the variant as "likely benign/benign." Based on the evidence outlined above, the variant was classified as likely benign.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000724288 SCV001133584 likely benign not provided 2019-07-08 criteria provided, single submitter clinical testing
ITMI RCV000120257 SCV000084409 not provided not specified 2013-09-19 no assertion provided reference population
Sharing Clinical Reports Project (SCRP) RCV000077572 SCV000109375 benign Breast-ovarian cancer, familial 1 2010-09-22 no assertion criteria provided clinical testing
Breast Cancer Information Core (BIC) (BRCA1) RCV000077572 SCV000145087 uncertain significance Breast-ovarian cancer, familial 1 2003-12-23 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.